Oncology & Cancer

Low rate of malignancy for BI-RADS category 3 lesions

(HealthDay)—A low malignancy rate is observed for Breast Imaging Reporting and Data System (BI-RADS) category 3 breast lesions detected by screening ultrasonography (US), according to research published in the December ...

Oncology & Cancer

Major changes urged for cancer screening and treatment

To address the growing problem of people being overdiagnosed and overtreated for cancer, a group of scientists convened by the National Cancer Institute and chaired by a UC San Francisco breast cancer expert is proposing ...

Oncology & Cancer

Identifying the drivers of breast cancer

Information on what causes breast cancer is sorely lacking, making early detection crucial. The sooner breast cancer is found, the greater the chance of treatment and cure.

Oncology & Cancer

DCIS Score quantifies risk of ipsilateral breast event

The ductal carcinoma in situ (DCIS) Score quantifies the risk of ipsilateral breast event (IBE) and invasive IBE risk, complements both traditional clinical and pathologic factors, and helps provide a new clinical tool to ...

page 8 from 14